Apr 17, 2024, 18:16
Jad Abdelsatta: Best papers of 2023 at ASBrS24
Jad Abdelsattar, Breast Surgical Oncologist at Banner Health, shared on X/Twitter:
”Excellent session this morning. Best papers of 2023. Some evidence to suggest that it might be acceptable to omit RT post-BCS in low-grade, small, and clinically node-negative breast cancers in older patients with ER high tumors who commit to 5 years of Endo treatment! ”
Source: Jad Abdelsatta/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 14:28
Nov 14, 2024, 14:05
Nov 14, 2024, 13:49
Nov 14, 2024, 13:44
Nov 14, 2024, 13:37
Nov 14, 2024, 13:32